Bicocca Open Archive

Logo unimib boa
SMITH, ANDREW
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.416
EU - Europa 4.645
AS - Asia 1.921
SA - Sud America 19
AF - Africa 13
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.297
IT - Italia 1.549
CN - Cina 729
DE - Germania 702
IE - Irlanda 631
SG - Singapore 624
SE - Svezia 493
RU - Federazione Russa 337
GB - Regno Unito 205
HK - Hong Kong 203
AT - Austria 199
UA - Ucraina 145
VN - Vietnam 132
CA - Canada 106
FR - Francia 89
DK - Danimarca 79
FI - Finlandia 61
IN - India 57
ID - Indonesia 54
TR - Turchia 38
NL - Olanda 33
BE - Belgio 22
JP - Giappone 20
CH - Svizzera 14
ES - Italia 14
KR - Corea 14
TW - Taiwan 14
CZ - Repubblica Ceca 13
BR - Brasile 11
MX - Messico 11
PL - Polonia 10
GR - Grecia 9
AU - Australia 8
NO - Norvegia 8
RO - Romania 8
HR - Croazia 7
TH - Thailandia 7
EG - Egitto 6
IL - Israele 6
IR - Iran 5
MY - Malesia 5
PT - Portogallo 5
PH - Filippine 4
BG - Bulgaria 3
EC - Ecuador 3
LT - Lituania 3
DZ - Algeria 2
KZ - Kazakistan 2
PE - Perù 2
SA - Arabia Saudita 2
SC - Seychelles 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BT - Bhutan 1
CL - Cile 1
CO - Colombia 1
EU - Europa 1
HU - Ungheria 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
Totale 14.025
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.696
Dublin 617
Fairfield 582
Chandler 581
Singapore 552
Milan 542
Frankfurt am Main 527
Wilmington 455
Ashburn 401
Woodbridge 365
Houston 311
Dearborn 301
Santa Clara 261
New York 253
Seattle 242
Hong Kong 191
Vienna 191
Princeton 188
Cambridge 184
Jacksonville 145
Shanghai 137
Nanjing 128
Dong Ket 111
Jakarta 53
Lawrence 49
Rome 46
Beijing 45
Nanchang 45
Altamura 41
Falls Church 37
Guangzhou 37
Lissone 37
Shenyang 37
Helsinki 35
London 35
San Diego 34
Fremont 32
Hebei 29
Andover 28
Ottawa 26
Toronto 26
Los Angeles 25
Changsha 23
Pune 23
Florence 22
Chicago 21
Jiaxing 21
Boardman 18
Cinisello Balsamo 18
Jinan 18
Lachine 18
Monza 18
Brussels 17
Pavia 17
Zhengzhou 17
Absecon 16
Caronno Pertusella 16
Norwalk 16
Brescia 15
Hangzhou 15
Ningbo 15
Tianjin 15
Madison 14
Montréal 14
Terni 14
Kunming 13
San Giuliano Milanese 13
Munich 12
Cagliari 11
Centro Municipality 11
Edmonton 11
Lille 11
Bonndorf 10
Carate Brianza 10
Hefei 10
Kiev 10
Padova 10
Washington 10
Fermignano 9
Melzo 9
Mountain View 9
Rho 9
Romola 9
Sacramento 9
Sesto San Giovanni 9
Verona 9
Dallas 8
Naples 8
Napoli 8
Ripalta Cremasca 8
San Mateo 8
Birmingham 7
Brno 7
Daejeon 7
Guangdong 7
Legnano 7
Minamikasugaoka 7
Paullo 7
Salt Lake City 7
Taipei 7
Totale 10.376
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 426
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 361
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 308
MALDI imaging in Fabry nephropathy: a multicenter study 298
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 272
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 270
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 269
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 264
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 262
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 261
The proteomic landscape of renal tumors 249
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 247
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 245
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 239
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 238
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 236
The putative role of MALDI-MSI in the study of Membranous Nephropathy 234
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 234
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 233
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 227
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 223
Proteomics for the diagnosis of thyroid lesions: Preliminary report 210
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 208
Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics 208
Proteomics for the study of new biomarkers in Fabry disease: State of the art 207
Tumor size, stage and grade alterations of urinary peptidome in RCC 205
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 204
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 198
Proteome analysis in thyroid pathology 196
MALDI-MSI in the study of glomerulonephritis: Possible molecular indicators of CKD progression 190
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 180
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 171
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 169
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 167
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 163
The role of fine needle aspiration of orbital lesions: A case series 160
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 159
Intraluminal proteome and peptidome of human urinary extracellular vesicles 158
Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas 156
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 156
A molecular imaging approach to individuate tumour infiltrating lymphocytes 155
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 154
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 148
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 146
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 145
Machine learning approaches in MALDI-MSI: clinical applications 145
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 140
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 138
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 138
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 134
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 131
MALDI-MS imaging in the study of glomerulonephritis 126
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 125
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 120
The putative role of MALDI-MSI in the study of Membranous Nephropathy 109
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 106
The putative role of MALDI-MSI in the study of Membranous Nephropathy 105
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 105
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 96
α-1-antitrypsin detected by MALDI-Imaging in the study of glomerulonephritis: its relevance in chronic kidney disease progression 96
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 96
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 94
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 90
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 90
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 90
The Reed-Stanton press rig for the generation of reproducible fingermarks: Towards a standardised methodology for fingermark research 88
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 87
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 86
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 86
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 86
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 86
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 84
Determining the Age of a Latent Fingermark: Applying a Novel MALDI-MSI Methodology to an Age Old Forensic Conundrum 83
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 82
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 79
Molecular indicators of the progression of chronic kidney disease: a MALDI-Imaging approach in the study of glomerulonephritis 77
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 75
Reproducible lipid alterations in patient-derived breast cancer xenograft ffpe tissue identified with maldi msi for pre-clinical and clinical application 74
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 73
Towards obtaining molecular signatures of glomerulonephritis by MALDI-MSI: Preliminary evidence 72
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 72
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 72
Precision medicine for Diabetic Nephropathy and Hypertensive Nephrosclerosis 70
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 69
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 68
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 68
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 67
Sample preparation considerations in MALDI-MS Imaging: What is your goal? 64
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 61
MALDI mass spectrometry imaging in the analysis of primary glomerulonephritis 61
Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients 61
Correlazione di dati ottenuti con l’immagine istologica e microdissezione virtuale 61
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 60
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 58
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 58
Towards obtaining molecular signatures of glomerulonephritis by MALDI-MSI: Preliminary evidence 57
Molecular indicators of the progression of chronic kidney disease: a MALDI-Imaging approach in the study of glomerulonephritis 55
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 52
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 51
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 44
Totale 14.530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.377 0 0 0 0 0 310 346 168 178 149 169 57
2020/20212.332 98 111 244 290 219 233 191 256 154 169 124 243
2021/20221.490 119 143 91 162 114 145 39 83 60 113 149 272
2022/20232.574 298 692 241 199 101 393 47 200 171 37 113 82
2023/20242.134 75 84 82 145 196 584 436 52 132 36 82 230
2024/20251.836 224 449 344 213 437 169 0 0 0 0 0 0
Totale 14.873